KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Work In Process: 2011-2019

Historic Work In Process for Emergent BioSolutions (EBS) over the last 9 years, with Dec 2019 value amounting to $89.7 million.

  • Emergent BioSolutions' Work In Process was N/A to $114.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $114.2 million, marking a year-over-year change of. This contributed to the annual value of $89.7 million for FY2019, which is 13.08% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Work In Process of $89.7 million as of FY2019, which was down 13.08% from $103.2 million recorded in FY2018.
  • Emergent BioSolutions' Work In Process' 5-year high stood at $103.2 million during FY2018, with a 5-year trough of $19.8 million in FY2016.
  • Over the past 3 years, Emergent BioSolutions' median Work In Process value was $89.7 million (recorded in 2019), while the average stood at $89.8 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Work In Process crashed by 39.40% in 2016, and later spiked by 286.46% in 2017.
  • Emergent BioSolutions' Work In Process (Yearly) stood at $32.7 million in 2015, then slumped by 39.40% to $19.8 million in 2016, then soared by 286.46% to $76.6 million in 2017, then soared by 34.73% to $103.2 million in 2018, then dropped by 13.08% to $89.7 million in 2019.